Literature DB >> 29488094

Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis.

Erdem Kisa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29488094     DOI： 10.1007/s00345-018-2245-3

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  4 in total

1.  Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.

Authors:  Aisha K Taylor; Teresa R Zembower; Robert B Nadler; Marc H Scheetz; John P Cashy; Diana Bowen; Adam B Murphy; Elodi Dielubanza; Anthony J Schaeffer
Journal:  J Urol       Date:  2012-02-16       Impact factor: 7.450

2.  Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.

Authors:  Stephen Taylor; Joseph Margolick; Zeid Abughosh; S Larry Goldenberg; Dirk Lange; William R Bowie; Robert Bell; Diane Roscoe; Lindsay Machan; Peter Black
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

3.  Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.

Authors:  Ender Ozden; Yakup Bostanci; Kamil Y Yakupoglu; Ekrem Akdeniz; Ali F Yilmaz; Necla Tulek; Saban Sarikaya
Journal:  Urology       Date:  2009-05-22       Impact factor: 2.649

4.  Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.

Authors:  Erdem Kisa; Mustafa Ugur Altug; Oguz Alp Gurbuz; Harun Ozdemir
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.